FI953957A - 1,4-dihydropyridiini-3,5-dikarboksyylihappoestereiden käyttö lääkeaineena - Google Patents
1,4-dihydropyridiini-3,5-dikarboksyylihappoestereiden käyttö lääkeaineena Download PDFInfo
- Publication number
- FI953957A FI953957A FI953957A FI953957A FI953957A FI 953957 A FI953957 A FI 953957A FI 953957 A FI953957 A FI 953957A FI 953957 A FI953957 A FI 953957A FI 953957 A FI953957 A FI 953957A
- Authority
- FI
- Finland
- Prior art keywords
- dihydropyridine
- drug
- dicarboxylic acid
- acid esters
- esters
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4430094A DE4430094A1 (de) | 1994-08-25 | 1994-08-25 | Verwendung von 3,5-Dicarbonsäureester-1,4-Dihydropyridinen als Arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
FI953957A0 FI953957A0 (fi) | 1995-08-23 |
FI953957A true FI953957A (fi) | 1996-02-26 |
Family
ID=6526498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI953957A FI953957A (fi) | 1994-08-25 | 1995-08-23 | 1,4-dihydropyridiini-3,5-dikarboksyylihappoestereiden käyttö lääkeaineena |
Country Status (14)
Country | Link |
---|---|
US (2) | US5665741A (fi) |
EP (1) | EP0705819A1 (fi) |
JP (1) | JPH0859468A (fi) |
KR (1) | KR960007563A (fi) |
CN (1) | CN1128757A (fi) |
AU (1) | AU3011295A (fi) |
CA (1) | CA2156673A1 (fi) |
DE (1) | DE4430094A1 (fi) |
EE (1) | EE9500055A (fi) |
FI (1) | FI953957A (fi) |
HU (1) | HUT74617A (fi) |
IL (1) | IL115030A0 (fi) |
NO (1) | NO953322L (fi) |
PL (1) | PL310146A1 (fi) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5568200A (en) | 1999-06-23 | 2001-01-09 | Ajinomoto Co., Inc. | Dihydropyridine derivative |
EP1479397B1 (en) * | 2002-02-05 | 2011-06-08 | Astellas Pharma Inc. | 2,4,6-triamino-1,3,5-triazine derivative |
US20050075359A1 (en) * | 2003-03-14 | 2005-04-07 | Rikako Kono | Large conductance calcium-activated K channel opener |
US10258498B2 (en) | 2011-11-24 | 2019-04-16 | Richter Gedeon Nyrt. | 1,4-dihydropyridine derivatives with Hsp modulating activity |
CN104710441B (zh) * | 2014-12-18 | 2017-01-18 | 苏州科技学院 | 吡啶五甲酸二钾化合物及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1813436C3 (de) * | 1968-12-07 | 1979-01-11 | Bayer Ag, 5090 Leverkusen | N-Substituierte 2,6-Dimethyl-l,4dihydropyridine |
DE1923990C3 (de) * | 1969-05-10 | 1978-11-23 | Bayer Ag | Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern |
US3883543A (en) * | 1969-05-10 | 1975-05-13 | Bayer Ag | N-alkyl-1,4-dihydropyridines |
JPS4899181A (fi) * | 1972-04-04 | 1973-12-15 | ||
DE2815578C2 (de) * | 1978-04-11 | 1986-01-16 | Bayer Ag, 5090 Leverkusen | Neue pharmazeutische Verwendung von Nimodipin |
EP0287828A1 (de) * | 1987-03-27 | 1988-10-26 | Byk Gulden Lomberg Chemische Fabrik GmbH | Neue Zwischenprodukte und Verfahren |
DE4011695A1 (de) * | 1990-04-11 | 1991-10-17 | Bayer Ag | Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung |
-
1994
- 1994-08-25 DE DE4430094A patent/DE4430094A1/de not_active Withdrawn
-
1995
- 1995-08-14 EP EP95112766A patent/EP0705819A1/de not_active Withdrawn
- 1995-08-17 AU AU30112/95A patent/AU3011295A/en not_active Abandoned
- 1995-08-18 JP JP7232035A patent/JPH0859468A/ja active Pending
- 1995-08-18 US US08/516,668 patent/US5665741A/en not_active Expired - Fee Related
- 1995-08-22 CA CA002156673A patent/CA2156673A1/en not_active Abandoned
- 1995-08-22 IL IL11503095A patent/IL115030A0/xx unknown
- 1995-08-23 FI FI953957A patent/FI953957A/fi unknown
- 1995-08-23 PL PL95310146A patent/PL310146A1/xx unknown
- 1995-08-24 NO NO953322A patent/NO953322L/no unknown
- 1995-08-24 CN CN95116647A patent/CN1128757A/zh active Pending
- 1995-08-24 EE EE9500055A patent/EE9500055A/xx unknown
- 1995-08-24 KR KR1019950026301A patent/KR960007563A/ko not_active Application Discontinuation
- 1995-08-25 HU HU9502509A patent/HUT74617A/hu unknown
-
1997
- 1997-03-28 US US08/828,464 patent/US5955482A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO953322D0 (no) | 1995-08-24 |
US5955482A (en) | 1999-09-21 |
CA2156673A1 (en) | 1996-02-26 |
CN1128757A (zh) | 1996-08-14 |
AU3011295A (en) | 1996-03-07 |
IL115030A0 (en) | 1995-12-08 |
EE9500055A (et) | 1996-04-15 |
JPH0859468A (ja) | 1996-03-05 |
NO953322L (no) | 1996-02-26 |
FI953957A0 (fi) | 1995-08-23 |
HU9502509D0 (en) | 1995-10-30 |
DE4430094A1 (de) | 1996-02-29 |
PL310146A1 (en) | 1996-03-04 |
HUT74617A (en) | 1997-01-28 |
EP0705819A1 (de) | 1996-04-10 |
US5665741A (en) | 1997-09-09 |
KR960007563A (ko) | 1996-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE211131T1 (de) | Arylsulfonylaminohydroxamsäurederivate | |
FI871492A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-tiometyyli-substituoitujen 1,4-dihydropyridiinien valmistamiseksi | |
DE69531834D1 (de) | Herstellung einer aerosolformulierung von insulin | |
FR12C0053I2 (fr) | Dihydropyridines a activite courte | |
FI954007A0 (fi) | Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena | |
NL192832B (nl) | 1,8 gebrugde 6-halogeen-4-chinolon-3-carbonzuurderivaten en farmaceutisch preparaat dat een dergelijk derivaat bevat. | |
NO951147D0 (no) | Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel | |
FI953957A (fi) | 1,4-dihydropyridiini-3,5-dikarboksyylihappoestereiden käyttö lääkeaineena | |
FI941149A0 (fi) | 2,4-diamino-3-hydroksikarboksyylihapon johdannaisia | |
NO960777D0 (no) | Anvendelse av N-alkylerte 1,4-dihydropyridin dikarboksylsyreestere som medikamenter | |
NO307704B1 (no) | 8-trifluormetylkinolinkarboksylsyre-derivat, medisinsk preparat inneholdende derivatet, samt anvendelse av et medisinsk preparat | |
ZA93210B (en) | Specific 1,4-dihydropyridine-3, 5-dicarboxylic acid ester, process for its preparation and its pharmaceutical use. | |
DE69419674D1 (de) | Optisch aktive 1,4-Dihydropyridinderivate und Verfahren zu ihrer Herstellung | |
DK0876367T3 (da) | Trans apovincaminsyreesterderivater som lægemidler | |
DE69609219D1 (de) | Peroxycarbonsäureester Photoinitiatoren abgeleitet von Stickstoff-Heterozyklen | |
DE69817868D1 (de) | 4-fluoro-3-oxocarbonsäureester und ihre herstellung | |
DE69305250D1 (de) | Herstellung von Alkandicarbonsäurederivaten | |
DK142287D0 (da) | Optisk aktive 1,4-dihydropyridinderivater | |
KR950702115A (ko) | 디히드로피리딘 유도체의 신규 의약 용도(novel medicinal use of dihydropyridine derivative) | |
DE59504642D1 (de) | Herstellung von carbaminsäurevinylestern | |
DE69527684D1 (de) | Herstellung von 3-oxy-5-oxo-6-Heptensäurederivaten | |
DE69502982D1 (de) | Herstellung geschützter Aminothiazolylessigsäurederivate | |
ZA935191B (en) | Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester, process for its preparation and its pharmaceutical use. | |
DE69614716D1 (de) | Dihydrat von (2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionsäure ester von 4,10-beta-diacetoxy-2alpha-benzoyloxy-5beta, 20-epoxy-1-hydroxy-9-oxo-19-nor-cyclopropa(g]tax-11-en-13alpha-yl und verfahren zu ihrer herstellung | |
DE59606925D1 (de) | 1,6-Naphthyridoncarbonsäurederivate |